Free Newsletter

  Email address:
   

Site Search
We're In the News
May 15, 2008
VC Investment:
China vs U.S.
March 20, 2008
State of China
Biotech Industry
 
CCTV-9 BizCHINA Interview

CCTV-9 BizCHINA Pharma Industry
March 10-15, 2008
>> Videos 

China: Dragon Lures Foreign Investors
StartUp Magazine
February, 2008
>> Free Preview

Interfax Interviews
Greg B. Scott

Interfax China
December, 2007

Sirnaomics on Track for 2008 Phase I in China

publication date: Dec 28, 2007
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.

Sirnaomics of Rockville, MD plans to begin a Phase I trial of its lead drug candidate in China during the year 2008. The molecule, called STP601, uses an RNA interference mechanism to target neovascularization in the eye. If Sirnaomics achieves its goal of starting a trial that soon, it would be a remarkable achievement because Sirnaomics is a very young company – it was formed earlier this year – and it has not depended on in-licensing any technology to speed its forward progress. In an exclusive interview, Dr. Lu, CEO of the company, talks about the future of the company. More details...

Stock Symbol (NYSE: NVS)




Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...


Login

 

 
   
Partners






Featured Events

July 7-8, 2008
Shanghai, China
 
July 10-11, 2008
Shanghai, China
 
September 16-18, 2008
  San Francisco, CA

>> More events...